Earnings Feed
Start Free
$SEM·8-K

SELECT MEDICAL HOLDINGS CORP · Apr 30, 4:40 PM ET

Compare

SELECT MEDICAL HOLDINGS CORP 8-K

Research Summary

AI-generated summary

Updated

Select Medical Holdings Corp Reports Q1 2026 Results, Declares Dividend

What Happened

  • On April 30, 2026, Select Medical Holdings Corporation filed an 8-K and issued a press release reporting its financial results for the quarter ended March 31, 2026 (Exhibit 99.1). The company also declared a cash dividend of $0.0625 per share payable on or about May 28, 2026 to shareholders of record at the close of business on May 14, 2026.
  • On April 28, 2026, the Compensation Committee approved one‑year delays to the scheduled vesting dates of specific equity award tranches granted under the 2020 Equity Incentive Plan for Executive Chairman Robert A. Ortenzio and Senior EVP Martin F. Jackson; each deferred tranche remains subject to continued service through the new vesting date.

Key Details

  • Press release dated April 30, 2026 discloses Q1 results for the period ended March 31, 2026 (Exhibit 99.1 attached to the 8-K).
  • Dividend: $0.0625 per share, payable on or about May 28, 2026; record date May 14, 2026.
  • Vesting deferrals (each deferred by one year):
    • Robert A. Ortenzio: 51,111 shares (4/30/2024 grant; vesting moved from 4/30/2026 → 4/30/2027), 83,333 shares (7/29/2025 grant; 7/29/2026 → 7/29/2027), 55,556 shares (8/1/2023 grant; 8/1/2026 → 8/1/2027).
    • Martin F. Jackson: 30,667 shares (4/30/2024; 4/30/2026 → 4/30/2027), 50,000 shares (7/29/2025; 7/29/2026 → 7/29/2027), 33,334 shares (8/1/2023; 8/1/2026 → 8/1/2027).

Why It Matters

  • The filing furnishes Select Medical’s latest quarterly results (earnings/revenue and related metrics are in the press release), and confirms a small cash dividend with defined record and payment dates—relevant for income-focused shareholders who must hold stock by May 14, 2026 to receive the payment.
  • The one‑year deferral of executive award vesting delays when those shares could be issued (and when executives realize value), which affects timing of potential share dilution and signals a retention-related change to executive compensation timing. Investors should review the full press release (Exhibit 99.1) for the detailed financial figures and any management commentary.

Loading document...